miR-204 expression is significantly dysregulated in CAVD and aortic stenosis, as are the miR-34 family members that are known to suppress BMP2; making these attractive miR-based therapeutic targets (137, 163, 165, 183, 217). The gene discussed is BMP2; the disease is aortic stenosis.